**Build our future together:**

The Executive Director, Global Patient Safety Sciences, Rare Disease is the first point of contact for all Rare Disease strategy-related responsibilities across clinical, and post-marketed drugs in the portfolio. As the product subject matter expert (SME) and Therapeutic Area Head (TAH) for the Rare Disease portfolio, this role defines the product safety strategy, establishes the medical safety opinion, and provides the safety scientific POV across both GPS and non-GPS interactions. In addition, the position acts as a trusted advisor to senior management regarding safety strategies/processes while developing organizational objectives and, importantly, understanding the impact of decisions across functional areas. The ED Global Patient Safety Sciences Rare Disease is responsible for the development of their team, which is comprised of GPS Leads. They will serve as a member of the GPS Leadership Team (GPS LT).

**When & where:** ​​